TABLE 1.
Cell | Injectant | n | KD | ΔH |
---|---|---|---|---|
μm | kcal/mol | |||
Lys48-diubiquitin | FAF1 UBA | 0.79 ± 0.01 | 3.5 ± 0.2 | −7.7 ± 0.64 |
UBL1-UBL2 | FAF1 UBA | ND | ||
UBX | FAF1 UBA | ND | ||
VCP N | FAF1 UBX | 1.13 ± 0.03 | 25.6 ± 2.1 | −4.3 ± 0.20 |
VCP N | FAF1 (TFPR → AG) | ND | ||
VCP N | Npl4 UBD | 1.04 ± 0.02 | 17.8 ± 1.4 | −5.1 ± 0.20 |
VCP ND1 | FAF1 UBX | 0.72 ± 0.05 | 22.7 ± 1.1 | −5.0 ± 0.51 |
VCP ND1 + ATP | FAF1 UBX | 0.61 ± 0.02 | 20.1 ± 1.7 | −5.1 ± 0.33 |
VCP ND1D2 | FAF1 UBX | ND | ||
VCP ND1D2 | FAF1 UAS-UBX | ND | ||
VCP ND1D2 + Ufd1-Npl4 | FAF1 UBX | 0.23 ± 0.11 | 08.4 ± 0.1 | −23.4 ± 13.83 |
VCP ND1D2 + Ufd1-Npl4 + ATP | FAF1 UBX | 0.27 ± 0.08 | 09.6 ± 0.2 | −18.3 ± 07.03 |
VCP ND1D2 + Ufd1-Npl4 + ATP | FAF1 UAS-UBX | 0.25 ± 0.09 | 19.5 ± 4.2 | −28.0 ± 16.47 |